Jeff Yass’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
Other funds holding ELTX
KCM
Jeff Yass's ELTX Position: Q3 2026 in Review
Jeff Yass opened a new position in Elicio Therapeutics (ELTX) in Q3 2026: 54,486 shares worth $99.2K. The stake represents ﹤0.01% of the portfolio and ranks #12563 among its holdings. This is a return to the name: Jeff Yass previously reported a position in ELTX as recently as Q1 2026.
Jeff Yass first reported a position in ELTX in Q2 2022 and has held it in 8 quarters since. The position peaked at $1.32M in Q3 2025. 80 funds tracked by Wall St. Rank hold ELTX as of Q3 2026.
- Jeff Yass held 54,486 shares of Elicio Therapeutics worth $99.2K as of Q3 2026.
- Elicio Therapeutics was a new Jeff Yass position in Q3 2026.
- Elicio Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12563 holding.
- Jeff Yass first reported a position in Elicio Therapeutics in Q2 2022 and has held it in 8 quarters since.
- Jeff Yass's Elicio Therapeutics position peaked at $1.32M in Q3 2025.
- 80 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.